Abstract
A retrospective analysis to determine the status of toxoplasma (IgG & IgM) antibodies in UAE women with recurrent fetal loss was done using immunofluorescence assay. Two thousand three hundred and fourty three patients with one or more fetal loss were studied over a period of five years.
In patients with fetal loss, the range of toxoplasma IgG seropositivity varied from 24.2–30.6%. There were 3 patients with IgM positive. Only in a single patient one of her two abortions could be attributed to acute toxoplasmosis.
Habitual fetal loss cannot be attributed to chronic toxoplasmosis. Also, 67.2% of the women of child bearing age group in U.A.E were found to be seronegative, highlighting the need for routine antenatal screening to detect primary acute toxoplasmosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
WHO publication. Report. of the WHO consultation on Public Health Aspects of Toxoplasmosis.WHO/CDS/VPH. 1988; 74: 2014.
Galvan Remirez M de la L, Soto Mancilla JL, Velasco Castrejon O, Perez Medina, RRev Soc Bras Med Trop. 1995; 29 (4): 333–337.
Sahwi SY, Zaki MS, Haiba NY, Elsaid OK, Anwar MY, AbdRabbo SA.J Obstet Gynaecol 1995; 21 (2): 145–148
Garin JP, Ambroise Thomas P, Cornet A, Kien Troung Thai, Despeignes,J Rev Instpasteur Lyon 1967–1968; 1: 179–205.
Stray-Pederson B. Toxoplasmosis in pregnancy.Bailliere’s Clinical Obs and Gynaecol 1993, 7: 107–137.
Lee RV. Parasites and pregnancy: the problems of malaria and toxoplasmosis.Clin Periatol 1988 15 : 351–63
Daffos F, Forestier F, Capella-Pavlovsky Met al. Prenatatl management of 746 p/egnancies at risk for congenital toxoplasmosisN Engl J Med 1988; 318: 271–275.
Desmonts G, Daffos, F, Forestier F, Capella Pavloysky M, Thuliez P, Chartier M. Prenatal diagnosis of congenital Toxoplasmosis.Lancet 1985; 1: 500–504.
Mitchell CD, Erlich SE, Mastrucci MTet al. Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus 2.Pediatr Infect Dis J ;1990; 9: 512–518.
Bessieres MH, Roques C and Seuela JP. Suggestion of a protocol to pervent congenital Toxoplasrnosis in tropical area.Bulletin de la Socite de Pathologie exitique et des ses Filiales. 1985; 78: 815–820.
Lappalainen M, Koskel P, Hedman Ket al. Incidence of pfimary toxplasma infection during pregnancy in Southern Finland.Scand J infeist Dis. 1992; 24: 97–104.
Alfors K Borjeson M. Huldt Get al. Incidence of Toxoplasmosis in pregnant women in the city of Malmo, Sweden,Scand J of Infect Dis. 1989; 21: 313–321.
Carter AO and Frank JW. Congenital Toxoplasmosis: epidemiological features and control.Canadian Med Assoc J 1986; 135: 618–623.
Guerina NG, Ho-Wen Hsu, Meissner HCet al. Neonatal serologic screening and early treatment for congenitalToxoplasma gondii infection.N Eng J Med 1994; 330: 1858–1863.
Hall SM. Congenitar ToxopiasmosisBr Med J 1992; 305: 291–297.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Singh, N. Status of toxoplasma antibodies in recurrent fetal loss in U.A.E. women. Indian J Pediatr 65, 891–897 (1998). https://doi.org/10.1007/BF02831357
Issue Date:
DOI: https://doi.org/10.1007/BF02831357